Welcome to our dedicated page for Next-Chemx SEC filings (Ticker: CHMX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating environmental risk disclosures or R&D spend inside NEXT-CHEMX CORP’s 200-page reports can slow decision-making. Chemical manufacturers juggle patents, sustainability pledges, and hazardous-material regulations—details that hide deep in footnotes. Our platform solves that complexity by turning every NEXT-CHEMX CORP SEC filing into clear, actionable insight.
Instant answers, form by form: the moment a NEXT-CHEMX CORP quarterly earnings report 10-Q filing or 8-K material event hits EDGAR, Stock Titan’s AI highlights shifts in segment revenue, new eco-friendly compound milestones, and any fresh environmental liabilities. Need the annual report 10-K simplified? Our AI-powered summaries translate technical terminology into plain English, so you understand patents, remediation costs, and sustainability metrics without combing through pages.
Real-time trading intelligence: track NEXT-CHEMX CORP insider trading Form 4 transactions as they post. Receive alerts on NEXT-CHEMX CORP executive stock transactions Form 4, compare activity to R&D announcements, and spot patterns before the market reacts. You can also dive into the proxy statement executive compensation section to see how leadership bonuses align with product launches.
- NEXT-CHEMX CORP Form 4 insider transactions real-time
- NEXT-CHEMX CORP earnings report filing analysis with AI
- Understanding NEXT-CHEMX CORP SEC documents with AI
- NEXT-CHEMX CORP 8-K material events explained
Whether you’re studying sustainability costs or simply want NEXT-CHEMX CORP SEC filings explained simply, our AI delivers the depth professionals need—without the hours they don’t.
NEXT-ChemX Corporation (CHMX) reported a Form 4 from a director showing termination of two unsigned subscription agreements dated 06/30/2025. The filing states a Subscription Agreement to purchase 10,000 shares of Series A Preferred Stock at $0.001 par (purchase price stated as $10,00 in the filing) and a separate Subscription Agreement to purchase 10,000 shares of Series F Preferred Stock for $10.00 were issued but never signed or executed and were terminated on 06/30/2025. The Form 4 records a disposition code "J" for both classes, with the reporting person showing 0 shares beneficially owned following the reported transactions. Series A Preferred would have carried 500 votes per share and convertible into 250 common shares per preferred if issued; Series F Preferred would have carried 1,000 votes per share and is not convertible, per the explanations in the filing.
John Michael Johnson, listed as President, CFO and a Director of NEXT-ChemX Corporation (CHMX), reported changes in his beneficial ownership. The filing shows prior indirect ownership of 1,311,445 common shares reflecting a 5.5% stake in a private controlling shareholder that holds 23,844,448 CHMX shares and is subject to ongoing litigation over an earlier Form 3 claim by Sparkie Properties LLC. Johnson holds 57,473 shares directly following earlier small acquisitions priced at $1 per share. On June 30, 2025 two Subscription Agreements for 10,000 Series A and 10,000 Series F preferred shares (each $0.001 par) were recorded as disposed, with both subscription agreements never executed and terminated the same day. The Series A would have carried 500 votes and conversion into 250 common shares per preferred; Series F would have carried 1,000 votes and was non-convertible. The report is signed by Johnson on October 2, 2025.
NEXT-ChemX Corporation reported amendments to insider transactions showing the company (listed as the reporting person) acquired preferred shares in two series. On 05/29/2024 the reporting person acquired 10,000 shares of Series A Preferred Stock for $0.001 per share (total reported consideration $10.00), leaving 10,000 Series A shares beneficially owned. Each Series A share carries 500 votes and is convertible into 250 shares of common stock at any time, with automatic conversion into common stock at that ratio if not converted by 5:00 P.M. Las Vegas time on January 1, 2026. On 09/23/2024 the reporting person acquired 10,000 shares of Series F Preferred Stock for $0.001 per share (10,000 shares beneficially owned). Each Series F share carries 1,000 votes and, per the filing, is not convertible. The Form is an amendment (4/A) with an amendment date of 10/02/2024 and includes a signature dated 10/01/2025 by Benton Wilcoxon.
John Michael Johnson, President and CFO and a director of NEXT-ChemX Corporation (CHMX), amended a Form 4 to report several transactions and holdings. The filing shows past common stock acquisitions (including 1,311,445 shares indirectly held, and additional direct purchases totaling 57,473 shares) and the issuance/purchase of 10,000 Series A Preferred and 10,000 Series F Preferred shares on 05/29/2024 and 09/23/2024 respectively. The Series A carries 500 votes per share and converts into 250 common shares; the Series F carries 1,000 votes per share and is stated as non-convertible in the text provided. The filing discloses an indirect ownership interest representing 5.5% of a private corporation that is the controlling shareholder of CHMX, which reportedly owns 23,844,448 shares; a separate Form 3 claim by Sparkie Properties LLC over 15,866,096 shares is noted as the subject of ongoing litigation in Texas. The amendment date is 10/02/2024 and the form is signed 10/01/2025.
NEXT-ChemX Corporation (CHMX) amended its Form 10-Q covering the quarter ended June 30, 2024. The company reported a six-month net loss of $939,787 versus a loss of $855,696 a year earlier and used $861,765 of cash in operating activities for the six months. Total current assets include marketable investments valued at $85,560 and reported total current assets of $616,875. The balance sheet shows significant payables including accrued payroll of $1,828,704 and other payables totaling multiple millions, with related-party payables and accrued expenses highlighted.
Management discloses a substantial doubt about the company’s ability to continue as a going concern, citing a working capital deficit since changing its business focus, reliance on shareholder funding, expected further losses until commercialization of its iTDE technology, and the need for additional capital.